When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
Stein
Karen
K
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004046:Dietetics / Q000379:methods*; D006801:Humans; D008019:Life Style; D001523:Mental Disorders / Q000188:drug therapy; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000209:etiology; D009765:Obesity / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control*; D010353:Patient Education as Topic; D015430:Weight Gain / Q000187:drug effects*
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents